209 related articles for article (PubMed ID: 16935796)
1. Topical imiquimod as treatment for different kinds of cutaneous lymphoma.
Coors EA; Schuler G; Von Den Driesch P
Eur J Dermatol; 2006; 16(4):391-3. PubMed ID: 16935796
[TBL] [Abstract][Full Text] [Related]
2. Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara).
Didona B; Benucci R; Amerio P; Canzona F; Rienzo O; Cavalieri R
Br J Dermatol; 2004 Jun; 150(6):1198-201. PubMed ID: 15214911
[TBL] [Abstract][Full Text] [Related]
3. Treatment of patch and plaque stage mycosis fungoides with imiquimod 5% cream.
Deeths MJ; Chapman JT; Dellavalle RP; Zeng C; Aeling JL
J Am Acad Dermatol; 2005 Feb; 52(2):275-80. PubMed ID: 15692473
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of primary cutaneous follicle centre lymphoma with topical 5% imiquimod.
Stavrakoglou A; Brown VL; Coutts I
Br J Dermatol; 2007 Sep; 157(3):620-2. PubMed ID: 17553050
[No Abstract] [Full Text] [Related]
5. Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series.
Lewis DJ; Byekova YA; Emge DA; Duvic M
J Dermatolog Treat; 2017 Sep; 28(6):567-569. PubMed ID: 28635518
[TBL] [Abstract][Full Text] [Related]
6. Full clinical recovery after topical acyclovir treatment of Epstein-Barr virus associated cutaneous B-cell lymphoma in patient with mycosis fungoides.
Copur MS; Deshpande A; Mleczko K; Norvell M; Hrnicek GJ; Woodward S; Frankforter S; Mandolfo N; Fu K; Chan WC
Croat Med J; 2005 Jun; 46(3):458-62. PubMed ID: 15861527
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides.
Dummer R; Urosevic M; Kempf W; Kazakov D; Burg G
Dermatology; 2003; 207(1):116-8. PubMed ID: 12835571
[TBL] [Abstract][Full Text] [Related]
8. Solitary plaque mycosis fungoides on the penis responding to topical imiquimod therapy.
Chiam LY; Chan YC
Br J Dermatol; 2007 Mar; 156(3):560-2. PubMed ID: 17300249
[TBL] [Abstract][Full Text] [Related]
9. Imiquimod 5% cream in the treatment of mycosis fungoides--a pilot study.
Chong A; Loo WJ; Banney L; Grant JW; Norris PG
J Dermatolog Treat; 2004 Apr; 15(2):118-9. PubMed ID: 15204164
[No Abstract] [Full Text] [Related]
10. Therapeutic Update: Update on Cutaneous and Systemic Therapy for Primary Cutaneous T Cell Lymphoma, Mycosis Fungoides.
Lo Sicco K; Latkowski JA
J Drugs Dermatol; 2015 Dec; 14(12):1381-3. PubMed ID: 26659928
[No Abstract] [Full Text] [Related]
11. Topical imiquimod therapy for cutaneous T-cell lymphoma.
Do JH; McLaughlin SS; Gaspari AA
Skinmed; 2003; 2(5):316-8. PubMed ID: 14673267
[No Abstract] [Full Text] [Related]
12. [Imiquimod in treatment of palpebral mycosis fungoides].
Soler-Machín J; Gilaberte-Calzada Y; Vera-Alvarez J; Coscojuela-Santaliestra C; Martínez-Morales J; Osán-Tello M
Arch Soc Esp Oftalmol; 2006 Apr; 81(4):221-3. PubMed ID: 16688647
[TBL] [Abstract][Full Text] [Related]
13. Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod.
Suchin KR; Junkins-Hopkins JM; Rook AH
Arch Dermatol; 2002 Sep; 138(9):1137-9. PubMed ID: 12224972
[No Abstract] [Full Text] [Related]
14. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
Mostow EN; Neckel SL; Oberhelman L; Anderson TF; Cooper KD
Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
[TBL] [Abstract][Full Text] [Related]
15. Imiquimod in mycosis fungoides.
Martínez-González MC; Verea-Hernando MM; Yebra-Pimentel MT; Del Pozo J; Mazaira M; Fonseca E
Eur J Dermatol; 2008; 18(2):148-52. PubMed ID: 18424373
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of imiquimod in solitary plaques of mycosis fungoides.
Onsun N; Ufacik H; Kural Y; Topçu E; Somay A
Int J Tissue React; 2005; 27(4):167-72. PubMed ID: 16440581
[TBL] [Abstract][Full Text] [Related]
17. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
[TBL] [Abstract][Full Text] [Related]
18. Unilesional cutaneous T-cell lymphoma: clinical features, therapy, and follow-up of 10 patients with a treatment-responsive mycosis fungoides variant.
Heald PW; Glusac EJ
J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):283-5. PubMed ID: 10642687
[TBL] [Abstract][Full Text] [Related]
19. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
[TBL] [Abstract][Full Text] [Related]
20. [Cutaneous lymphomas].
Schad K; Baumann Conzett K; Cozzio A
Ther Umsch; 2010 Sep; 67(9):453-64. PubMed ID: 20806174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
